Articles Archive - Page 636 of 808

Letters: Importance of Rheumatologic Physical Exam

Stephen Soloway, MD | October 1, 2013

A rheumatologist stresses the need for more thorough exams in the context of one patient’s hospital admission for stroke

Letters: Reflections on Rheumatology Fellowship Guidelines

Al Masi, MD, DRPH | October 1, 2013

A physician suggests the educational responsibilities and priorities of rheumatology fellows should reinforce person- and patient-centered management

Letters: Rheumatologists’ Role in Arthritis Support Groups

Naomi Creek | October 1, 2013

How physicians can help patients find social groups, the Arthritis Foundation, and online support services for people with arthritis

Rheuminations: The Power of the Placebo

Simon M. Helfgott, MD | October 1, 2013

Can rheumatologists harness the placebo effect to improve patient care?

President’s Perspective: Outgoing ACR Leader Audrey B. Uknis, MD, Forecasts Bright Future for Rheumatology

Audrey B. Uknis, MD | October 1, 2013

Strides in strategic planning, advocacy, education, leadership development, and research during 2013 have well-positioned the College to advance rheumatology

ACR’s Simple Tasks Campaign Gains Ground in Washington, D.C.

Kimberly Retzlaff | October 1, 2013

After two years, the public awareness effort to increase the value of rheumatology resonates with Congressional legislators, referring physicians, health professionals

ACR Issues sJIA Recommendations, SSc Classification Criteria

Kathy Holliman | October 1, 2013

Guidelines address advances in pathophysiology and treatment of systemic juvenile idiopathic arthritis; criteria classify broader spectrum of systemic sclerosis

New Insights into CPPD

Robert Terkeltaub, MD | October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Supreme Court Decision on Gene Patents Good News for Clinicians, Researchers

Richard Quinn | September 24, 2013

The recent U.S. Supreme Court decision that ruled human genes cannot be patented may provide greater access to genetic testing. (posted Sept. 24, 2013)

Dermatology Case Answer E: September

Alisa Femia, MD and Joseph F. Merola, MD | September 18, 2013

Incorrect E) Mycosis fungoides (MF) MF is a form of CTCL. As mentioned earlier, there is controversy over whether PPD is associated with MF, but many authors believe that PPD merely shares overlapping clinical features with certain rare subtypes of MF. MF can manifest with a wide variety of clinical lesions, including thin scaly patches,…